Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Revvity Inc (RVTY) vs Wayfair Inc (W) Price & Performance

Revvity IncTrade
Wayfair IncTrade

Price performance (Past 24H)

Key statistics

Revvity Inc vs Wayfair Inc — how do they compare? Revvity Inc trades at $154.98 (market cap $16.98B), while Wayfair Inc trades at $105.78 (market cap $14.40B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.18% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and Wayfair Inc for 8 Days on average.

RVTYW
Market Cap
$16.98B$14.40B
Volume
1,456,9002,102,856
Sector
HealthConsumer Cyclical
52-Week High
$157.36$119.05
52-Week Low
$82.26$57.40
Typical Hold Time
12 Days8 Days
Enterprise Value
$19.30B$16.73B
Dividend Yield
0.18%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Revvity Inc

Revvity (RVTY) trades at $154.33, up 0.48% on the day and near its 52-week high of $158.28. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and positive analyst upgrades reflect solid fundamentals. Key developments include the launch of a new Type 1 diabetes screening kit in Europe and the acquisition of Human Cell Design to bolster metabolic disease research, signaling growth in diagnostics and life sciences.

The outlook remains positive given consistent earnings outperformance and strategic expansions, though rich valuation multiples pose a risk if growth moderates. Investors face near-term headwinds from margin pressures in China and elevated P/E ratios, but institutional accumulation and a lack of sell ratings support a constructive bias for long-term holders.

Wayfair Inc

Wayfair (W) trades at $105.89, up 1.36% with bullish technical signals from moving averages. The company shows revenue growth to $12.9B in 2026 but maintains negative net margins around -2.5%. Recent Q2 2026 earnings beat expectations at $0.95 EPS versus $0.904, while Q3 2026 results are pending. Analyst sentiment is positive with 54% buy ratings and a $114.13 consensus target. The stock faces headwinds from high debt-to-asset ratio of 95.11% and persistent unprofitability despite top-line expansion.

Wayfair presents a mixed outlook with strong revenue growth and technical momentum offset by profitability challenges. The primary opportunity lies in continued market share gains and operational efficiency improvements. Key risks include competitive pressures in e-commerce, high leverage, and macroeconomic sensitivity. Investors should weigh the bullish analyst consensus against fundamental weaknesses in margin performance.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RVTY
0% Buy100% Sell
Avg holding period · 12 Days
W

No sentiment data available yet.

Top news

Latest headlines on both assets

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →

About Wayfair Inc

Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.

Read more on W →